disulfiram has been researched along with Fatty Liver, Nonalcoholic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, Y | 1 |
| Tang, L | 1 |
| Chen, Q | 1 |
| Wu, L | 1 |
| He, W | 1 |
| Tu, D | 1 |
| Wang, S | 1 |
| Chen, Y | 1 |
| Liu, S | 1 |
| Xie, Z | 1 |
| Wei, H | 1 |
| Yang, S | 1 |
| Tang, B | 1 |
1 trial available for disulfiram and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism.
Topics: Bile Acids and Salts; Clostridium; Disulfiram; Gastrointestinal Microbiome; Humans; Liver; Non-alcoh | 2022 |